top of page

What does it take to build a biotech startup in US?

Updated: Jul 3

Kerstin Sinkevicius (USA), Vice-President and Head of Pharmacology at BridgeBio Oncology Therapeutics (BBOT), which has just completed an oversubscribed $200M private funding round, shared her story and tips for success during a #WomenWithWings lunch for female entrepreneurs, executives, and investors.



Kerstin Sinkevičius is leading the pharmacology team responsible for the development of candidate selection and IND-enabling studies to support the advancement of next-generation KRAS-G12C ON inhibitor, first-in-class PI3Kα:RAS breaker, and panKRAS inhibitor programs. She has shared her professional journey, "broken ladder" challenges on the way, and lessons learned with tips for fellow women entrepreneurs, executives, and investors.


BridgeBio Oncology Therapeutics is a clinical-stage biopharmaceutical company advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3K malignancies, to improve outcomes for patients with cancers driven by the two most prevalent oncogenes in human tumors.


Women With Wings is an informal initiative to host events for women investors, founders, and executives, aiming to strengthen professional networks, learn from personal experiences, and bring more success to professional endeavors. The event was co-hosted by Viktorija Trimbel, Managing Director of Coinvest Capital, and Inga Langaitis, former CEO of the Unicorns Lithuania, with Sandra Golbreight, General Partner at Baltic Sandbox Ventures, and Agneta Skardžiuvienė, CEO at Association Lyderė.


What next?



Event photos by Rytis Šeškaitis



86 views0 comments

Comments